Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease

Background. Cystic fibrosis (CF) is a genetic disease that results in chronic infections of the lungs. CF patients experience intermittent pulmonary exacerbations (CFPE) that are associated with poor clinical outcomes. CFPE involves an increase in disease symptoms requiring more aggressive therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Quinn, Robert A., Lim, Yan Wei, Mak, Tytus D., Whiteson, Katrine, Furlan, Mike, Conrad, Douglas, Rohwer, Forest, Dorrestein, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2016
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991883/
https://www.ncbi.nlm.nih.gov/pubmed/27602256
http://dx.doi.org/10.7717/peerj.2174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991883/
https://www.ncbi.nlm.nih.gov/pubmed/27602256
http://dx.doi.org/10.7717/peerj.2174

Ejemplares similares